Ms. Padilla is an accomplished leader in the field of using innovation to improve clinical research and how medicines are brought to market. She brings over 20 years of consulting and industry experience working with senior leadership at pharma, biotech, and clinical research organization and is a frequent speaker at national and international digital health conferences. At IQVIA, she founded the digital health consulting group and was part of the team to develop StudyHub, the firm’s decentralized trial offering. Before joining IQVIA, Nelia spent more than eight years at Strategy&, a PwC company (formerly Booz & Company) where she co-led the Personalized Medicine offering. Prior to starting her consulting career, Ms. Padilla spent over seven years working in regulatory affairs for pharmaceutical and biotechnology firms in the US, Canada and Europe, including Serono and Cell Therapeutics, helping to bring oncology and multiple sclerosis products to the market. Ms. Padilla earned a bachelor’s degree in biology from Harvard University and a Master of Business Administration from the Yale School of Management.